Marvel CEO Isaac Perlmutter and his wife Laura have donated $9 million to help fund cancer research at NYU Langone Medical Center and the Technion-Israel Institute of Technology.
According to an announcement made today by the institutions, $3 million will finance six cancer-focused projects conducted by teams led by investigators from NYU Langone and the Technion. The remaining $6 million be used to establish a state-of-the-art research facility on Technion's Israel campus that will support these and other projects. Its principal focus will be on the emerging field of cancer metabolomics.
The former co-owner of Toy Biz, Isaac Perlmutter and his then business partner Avi Arad took control of Marvel in 1998, led the company out of bankruptcy and, within a decade, established Marvel Studios as a major player in Hollywood. A self-made billionaire, the publicity-shy Perlmutter made $1.5 billion in cash and stock from the 2009 sale of Marvel, becoming Disney's second-largest individual shareholder and one of the wealthiest people in the United States.
Longtime supporters of cancer research, the Perlmutters in January 2014 donated $50 million to advance cancer research and treatment at NYU Langone, which renamed the NYU Cancer Institute the Laura and Isaac Perlmutter Cancer Center at NYU Langone. The Perlmutters serve on the board of trustees at NYU Langone.
“Ike and I have long sought for ways to link the state of the art scientific and research advances being made in Israel with our deep commitment to NYU Langone Medical Center,” Laura Perlmutter said in a statement. “The partnership between the Technion and NYU Langone allows us to launch a focused cancer research and treatment approach. We are confident that this collaborative effort, which avoids duplication of research initiatives and creates efficiencies among marquee donors and researchers, will lead to dramatic results in the fight against this terrible disease.”